Long-term cognitive and functional effects of potentially inappropriate medications in older women

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69, Issue 4, 2014, Pages 423-429

  Koyama, Alain ^a,b   Steinman, Michael ^b,c   Ensrud, Kristine ^d,e   Hillier, Teresa A ^f   Yaffe, Kristine ^b,g  

^a NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e VA MEDICAL CENTER   (United States)

^f CENTER FOR HEALTH RESEARCH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognitive aging; Dementia; Epidemiology; Medication; Physical function.

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COGNITION; COGNITIVE AGING; DEMENTIA; DRUG EFFECT; DRUG THERAPY; EPIDEMIOLOGY; FEMALE; FOLLOW UP; HUMAN; MEDICATION ERROR; MOTOR ACTIVITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSICAL FUNCTION.; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; TIME; VERY ELDERLY;

COGNITIVE AGING; DEMENTIA; EPIDEMIOLOGY; MEDICATION; PHYSICAL FUNCTION.;

AGED; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; COGNITION; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MEDICATION ERRORS; MOTOR ACTIVITY; PROSPECTIVE STUDIES; QUESTIONNAIRES; TIME FACTORS;

EID: 84898969821     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt192     Document Type: Article

References (41)

1. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-2724. doi:10.1001/archinte. 163.22.2716
2. Mort JR, Aparasu RR. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med. 2000;160:2825-2831
3. Barton C, Sklenicka J, Sayegh P, Yaffe K. Contraindicated medication use among patients in a memory disorders clinic. Am J Geriatr Pharmacother. 2008;6:147-152. doi:10.1016/j.amjopharm. 2008.08.002
4. Somers M, Rose E, Simmonds D, Whitelaw C, Calver J, Beer C. Quality use of medicines in residential aged care. Aust Fam Physician. 2010;39:413-416
5. Field TS, Gilman BH, Subramanian S, Fuller JC, Bates DW, Gurwitz JH. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care. 2005;43:1171-1176
6. Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system- active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50:1629-1637
7. Dedhiya SD, Hancock E, Craig BA, Doebbeling CC, Thomas J, 3rd. Incident use and outcomes associated with potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother. 2010;8:562-570. doi:10.1016/S1543- 5946(10)80005-4
8. Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-Term benzodiazepine use: A meta-Analysis. CNS Drugs. 2004;18:37-48
9. Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: A clinical review. Clin Interv Aging. 2009;4:225-233
10. Billioti De Gage S, Begaud B, Bazin F, et al. Benzodiazepine use and risk of dementia: Prospective population based study. BMJ. 2012;345:e6231
11. Lai HY, Hwang SJ, Chen YC, Chen TJ, Lin MH, Chen LK. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Clin Ther. 2009;31:1859-1870. doi:10.1016/j.clinthera.2009.08.023
12. Egger SS, Bachmann A, Hubmann N, Schlienger RG, Krahenbuhl S. Prevalence of potentially inappropriate medication use in elderly patients: Comparison between general medical and geriatric wards. Drugs Aging. 2006;23:823-837
13. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767-773
14. Sheikh JL, Yesavage JA. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clin Gerontologist. 1986;5:165-173
15. Goldberg D, Bridges K, Duncan-Jones P, Grayson D. Detecting anxiety and depression in general medical settings. BMJ. 1988;297:897-899
16. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213
17. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994;10:405-411
18. Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: A review and practical application. Aging Health. 2008;4:311-320
19. Campbell NL, Boustani MA, Lane KA, et al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology. 2010;75:152-159. doi:10.1212/WNL.0b013e3181e7f2ab
20. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills. 1958;8:271-276
21. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314-318
22. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test: Second Edition (CVLT-II). San Antonio, TX: Psychological Corp; 2000
23. The Psychological Corporation. WAIS-III/WMS-III Technical Manual: Updated. San Antonio, TX; 2002
24. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. New York, NY: Oxford University Press; 1991
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373-383
26. Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: The medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59:1477-1483. doi:10.1111/j.1532-5415.2011.03491.x
27. Carriere I, Fourrier-Reglat A, Dartigues JF, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: The 3-city study. Arch Intern Med. 2009;169:1317-1324. doi:10.1001/archinternmed.2009.229
28. Bongue B, Naudin F, Laroche ML, et al. Trends of the potentially inappropriate medication consumption over 10 years in older adults in the East of France. Pharmacoepidemiol Drug Saf. 2009;18:1125-1133. doi:10.1002/pds.1762
29. Weston AL, Weinstein AM, Barton C, Yaffe K. Potentially inappropriate medication use in older adults with mild cognitive impairment. J Gerontol A Biol Sci Med Sci. 2010;65:318-321
30. Murphy KJ, Rich JB, Troyer AK. Verbal fluency patterns in amnestic mild cognitive impairment are characteristic of Alzheimer's type dementia. J Int Neuropsychol Soc. 2006;12:570-574
31. Henry JD, Crawford JR, Phillips LH. Verbal fluency performance in dementia of the Alzheimer's type: A meta-Analysis. Neuropsychologia. 2004;42:1212-1222. doi:10.1016/j.neuropsychologia.2004.02.001
32. Hall JR, Vo HT, Johnson LA, Barber RC, O'Bryant SE. The Link between Cognitive Measures and ADLs and IADL Functioning in Mild Alzheimer's: What Has Gender Got to Do with It? Int J Alzheimers Dis. 2011;2011:276734. doi:10.4061/2011/276734
33. Terrell KM, Perkins AJ, Dexter PR, Hui SL, Callahan CM, Miller DK. Computerized decision support to reduce potentially inappropriate prescribing to older emergency department patients: A randomized, controlled trial. J Am Geriatr Soc. 2009;57:1388-1394. doi:10.1111/j.1532-5415.2009.02352.x
34. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: A randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89:845-854. doi:10.1038/clpt.2011.44
35. Wolkove N, Elkholy O, Baltzan M, Palayew M. Sleep and aging: 2. Management of sleep disorders in older people. CMAJ. 2007;176:1449-1454. doi:10.1503/cmaj.070335
36. Montgomery P, Lilly J. Insomnia in the elderly. Clin Evid (Online). 2007;2007
37. Chancellor M, Boone T. Anticholinergics for overactive bladder therapy: Central nervous system effects. CNS Neurosci Ther. 2012;18:167-174. doi:10.1111/j.1755-5949.2011.00248.x
38. Moga DC, Carnahan RM, Lund BC, et al. Risks and Benefits of Bladder Antimuscarinics Among Elderly Residents of Veterans Affairs Community Living Centers. J Am Med Dir Assoc. 2013. doi:10.1016/j.jamda.2013.03.008
39. Halme AS, Beland SG, Preville M, Tannenbaum C. Uncovering the source of new benzodiazepine prescriptions in community-dwelling older adults'. Int J Geriatr Psychiatry. 2012;28:248-255. doi:10.1002/ gps.3818
40. Johnell K, Weitoft GR, Fastbom J. Sex differences in inappropriate drug use: A register-based study of over 600, 000 older people. Ann Pharmacother. 2009;43:1233-1238. doi:10.1345/aph.1M147
41. Bierman AS, Pugh MJ, Dhalla I, et al. Sex differences in inappropriate prescribing among elderly veterans. Am J Geriatr Pharmacother. 2007;5:147-161. doi:10.1016/j.amjopharm.2007.06.005.